WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,50Â US$
arrow_upward
+1,21%(+0,15) 1D
15. okt., 16.00.00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for WXXWY...
Ă…bn
12,00Â US$
Høj
12,60Â US$
Lav
12,00Â US$
Markedsværdi
198,43Â mia.
Gns. vol.
62,05Â t
Volumen
33,89Â t
Højeste i 52 uger
14,80Â US$
Laveste i 52 uger
7,30Â US$
Beta
0,01
Aktier i omløb
2,06Â mia.
Antal ansatte
15Â t
Ă…bn
12,00Â US$
Høj
12,60Â US$
Lav
12,00Â US$
Markedsværdi
198,43Â mia.
Gns. vol.
62,05Â t
Volumen
33,89Â t
Højeste i 52 uger
14,80Â US$
Laveste i 52 uger
7,30Â US$
Beta
0,01
Aktier i omløb
2,06Â mia.
Antal ansatte
15Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 26 minutter siden
S&P 500-futures stiger, mens investorerne forlader teknologiaktier
The Daily News | Texas' Oldest Newspaper
·
for 17 minutter siden
FILE PHOTO: Signage is seen outside the New York Stock Exchange (NYSE) in Manhattan, New York City
Stock Titan
·
for 50 minutter siden
32 new hires get awards tied to 57,853 shares, but vesting depends on continued employment.
MarketWatch
·
for 1 time siden
Nearly 40% of the S&P 500 is in a bear market. Here are 10 of those stocks that analysts say can gain up to 81%.
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om Wuxi Biologics Cayman ADR
Administrerende direktørZhisheng Chen
Ansatte14,7Â t
Grundlagt2010
Hovedsæde-
Sektor-
Websitewuxibiologics.com